These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8672826)

  • 1. Oral vitamin K1: an option to reduce warfarin's activity.
    Harrell CC; Kline SS
    Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
    Fan J; Armitstead JA; Adams AG; Davis GA
    Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: oral vitamin K1 to reverse warfarin activity.
    Weathermon RA; Heyscue BE; Garris RE
    Ann Pharmacother; 1996; 30(7-8):886-7. PubMed ID: 8826584
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.
    Fetrow CW; Overlock T; Leff L
    J Clin Pharmacol; 1997 Aug; 37(8):751-7. PubMed ID: 9378848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of various phytonadione (vitamin K1) administration routes in achieving warfarin reversal.
    Laible B
    S D Med; 2007 Apr; 60(4):158-9. PubMed ID: 17555152
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous vitamin K1 injections: dangerous prophylaxis.
    O'Reilly RA; Kearns P
    Arch Intern Med; 1995 Oct; 155(19):2127-8. PubMed ID: 7575074
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
    Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
    Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 13. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione.
    Raj G; Kumar R; McKinney WP
    Arch Intern Med; 1999 Dec 13-27; 159(22):2721-4. PubMed ID: 10597763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon.
    Penning-van Beest FJ; Rosendaal FR; Grobbee DE; van Meegen E; Stricker BH
    Br J Haematol; 1999 Feb; 104(2):241-5. PubMed ID: 10050703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.
    Patel RJ; Witt DM; Saseen JJ; Tillman DJ; Wilkinson DS
    Pharmacotherapy; 2000 Oct; 20(10):1159-66. PubMed ID: 11034038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
    Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
    Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
    Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
    Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
    Zhang H; Li M; Ao XL; Dong YJ; Dong L
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio.
    Byrd DC; Stephens MA; Hamann GL; Dorko C
    Am J Health Syst Pharm; 1999 Nov; 56(22):2312-5. PubMed ID: 10582823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
    Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
    Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.